Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
PCR
Long COVID less likely after Omicron than after original virus, Swiss researchers find
In a Swiss study, investigators have found that long COVID is less likely after Omicron infection than after infection by the original wild-type SARS-CoV-2 virus.
March 9, 2023
Servier, Qiagen partner to develop companion diagnostic test for AML
Under a master collaboration agreement, Qiagen will develop and validate a real-time PCR-based in vitro diagnostic test that can be used to detect IDH1 gene mutations in whole blood and bone marrow aspirates in AML.
March 9, 2023
Virufy nabs BARDA contract to develop cough- and speech-based COVID-19 detection technology
The project supports the firm’s aim to research and develop COVID-19 screening tools using artificial intelligence (AI)/machine learning (ML) technology.
March 8, 2023
Bio-Rad Laboratories revenue growth flat in Q4
Revenue increased almost 11% on a currency-neutral basis when COVID-related sales comparisons were excluded.
February 17, 2023
LumiraDx obtains FDA authorization for test to detect flu A, flu B, SARS-CoV-2
The test leverages a single-step direct method for nucleic acid extraction and amplification on validated open RT-PCR instruments.
February 7, 2023
Thermo Fisher Scientific obtains FDA EUA for monkeypox/orthopox virus DNA kit
The test is intended for the qualitative detection of DNA from monkeypox virus (clade I/II) and screening for non-variola orthopoxviruses in human lesion swab specimens.
December 15, 2022
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Quest Diagnostics offers suite of services for transplant patients and living donors
Rapid nirmatrelvir treatment in study reduced long-COVID risk
BioGX launches portable qPCR platform with CE-IVD marked assays outside U.S.
The expanded availability of its products complements a recent FDA expanded Emergency Use Authorization for the Xfree COVID-19 Direct RT-PCR running on the portable PCR platform.
December 12, 2022
Cepheid says its influenza assays mitigate impact of mutational drift seen in some tests
Two mutations in the matrix genes of the human influenza A virus have been reported to cause matrix gene target failure for several commercial diagnostic tests.
December 8, 2022
Eurofins launches droplet digital PCR assay to detect SARS-CoV-2 variants of concern in wastewater
The assay detects Omicron subvariants BQ.1 and BQ.1.1, which currently make up more than 35% of the SARS-CoV-2 virus variant distribution in the U.S. and which are increasing at rates superseding all other current SARS-CoV-2 variants, the firm noted.
December 5, 2022
High-throughput lab near UPS facility to provide rapid PCR test results
HealthTrackRx has opened a high-throughput laboratory in Clarksville, IN, to enable the rapid delivery of PCR test results.
November 18, 2022
Roche obtains FDA authorization for monkeypox test on high-throughput MDx system
Roche's Cobas MPXV test targets two different regions of the MPXV genome which are both less prone to mutations than other parts of the genome, the firm said.
November 16, 2022
Sentinel Diagnostics launches automated PCR system and assays to detect viral infections
Its Stat-Nat SN200 kits leverage freeze-dried technology that allows long-term stability at room temperature for the quantitative detection of ten viruses, Sentinel said.
November 14, 2022
Page 1 of 21
Next Page
